Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seizure Treatment IN Glioma (STING): Comparing a Treatment Strategy With Levetiracetam Versus Treatment With Valproic Acid in Glioma Patients With a First Seizure

NCT03048084 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT03048084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03048084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seizure Treatment IN Glioma (STING): Comparing a Treatment Strategy With Levetiracetam Versus Treatment With Valproic Acid in Glioma Patients With a First Seizure
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
February 1, 2018
Completion date
July 1, 2029
Enrollment
120 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

glioma